Skip to main content

Commodore Capital LP

Position in AVTX — Avalo Therapeutics, Inc.

CIK 1831942 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,818,535
+$11,607,345 QoQ
Shares Held
1,018,319
+110.8% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#23
of 126 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. AVTX ranks #19 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,818,535 1,018,319
2026-06-11 $78,207,560 5,721,109
2026-03-31 $7,211,190 483,000
2025-12-31 $8,771,280 483,000
2025-09-30 $6,138,930 483,000
2025-06-30 $2,410,170 483,000
2025-03-31 $3,868,830 483,000
2024-12-31 $3,588,690 483,000
2024-09-30 $4,588,500 483,000
2024-06-30 $498,800 40,000